Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

Critical Care Medicine

Volumn 28, Issue 4, 2000, Pages 977-983

  Müller, Beat ^a   Becker, Kenneth L ^b   Schächinger, Hartmut ^a   Rickenbacher, Peter R ^a   Huber, Peter R ^a   Zimmerli, Werner ^a   Ritz, Rudolf ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Acute disease; Antibiotics; Biological markers; Calcitonin; Critical illness; Diagnosis; Differential diagnosis; Infection; Inflammation; Protein precursors; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; LACTIC ACID; PROCALCITONIN;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0034060554     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004000-00011     Document Type: Article

References (58)

1. 1. Parillo JE, Parker MM, Natanson C, et al: Septic shock: Advances in the understanding of pathogenesis, cardiovascular dysfunctions, and therapy. Ann Intern Med 1990; 113: 227-242
2. 2. Tran DD, Groeneveld BJ, van der Meulen J, et al: Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990; 18: 474-479
3. 3. Brun-Buisson C, Doyon F, Carlet J, et al: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 1995; 274:968-974
4. 4. Manship L, McMillin RD, Brown JJ: The influence of sepsis and multisystem organ failure on mortality in the surgical intensive care unit. Am Surg 1984; 50:94-101
5. 5. Niederman MS, Fein AM: Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: A common clinical sequence. Clin Chest Med 1990; 11:633-650
6. 6. Lowry SF: Sepsis and its complications: Clinical definitions and therapeutic prospects. Crit Care Med 1994; 22:S1-S2
7. 7. Executive Summary of an American College of Chest Physicians, National Institute of Allergy and Infectious Disease, and National Heart, Lung, and Blood Institute Workshop: From the bench to the bedside: The future of sepsis research. Chest 1997; 111:744-753
8. 8. Warren HS: Strategies for the treatment of sepsis. N Engl J Med 1997; 336:952-953
9. 9. Bryant RE, Hood AF, Hood CE, et al: Factors affecting mortality of gram-negative bacteremia. Arch Intern Med 1971; 127:120-128
10. 10. Bryan CS, Reynold KL, Brenner ER: Analysis of 1186 episodes of gram-negative bacteremia in non-university hospitals: The effects of antimicrobial therapy. Rev Infect Dis 1983; 5:629-638
11. 11. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
12. 12. Schwartz B, Bell DM, Hughes JM: Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA 1997; 278: 944-945
13. 13. Cohen FL, Tartasky D: Microbial resistance to drug therapy: A review. Am J Infect Control 1997; 25:51-64
14. 14. Lingnau W, Allerberger F: Control of an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) by hygienic measures in a general intensive care unit. Infection 1994; 22:135-139
15. 15. Becker KL, Nylén ES, Cohen R, et al: Calcitonin gene family of peptides. In: Principles and Practice of Endocrinology and Metabolism. Becker KL (Ed). Second Edition. Philadelphia, JB Lippincott, 1995, pp 474-483
16. 16. Mallet E, Lanse X, Devaux AM, et al: Hypercalcitoninaemia in fulminant meningococcaemia in children. Lancet 1983; i:294
17. 17. Chesney RW, McCarron DM, Haddad JG, et al: Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 1983; 101:576-585
18. 18. Becker KL, Silva OL, Snider RH, et al: The pathophysiology of pulmonary calcitonin. In: The Endocrine Lung in Health and Disease. Becker KL, Gazdar AF (Eds). Philadelphia, WB Saunders, 1984, pp 277-279
19. 19. Assicot M, Gendrel D, Carsin H, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518
20. 20. Lind L, Bucht E, Ljunghall S: Pronounced elevation in circulating calcitonin in critical care patients is related to the severity of illness and survival. Intensive Care Med 1995; 21:63-66
21. 21. Gendrel D, Assicot M, Raymond J, et al: Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128: 570-573
22. 22. de Werra I, Jaccard C, Corradin SB: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25:607-613
23. 23. Gérard Y, Hober D, Assicot M, et al: Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. J Infect 1997; 35:41-46
24. 24. Young LS: Sepsis syndrome. In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds). Fourth Edition. New York, NY, Churchill Livingston, 1995, pp 690-705
25. 25. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
26. 26. Wagner DP, Knaus WA, Harrell FE, et al: Daily prognostic estimates for critically ill adults in intensive care units: Results from a prospective, multicenter, inception cohort analysis. Crit Care Med 1994; 22:1359-1372
27. 27. Castella X, Artigas A, Bion J, et al: A comparison of severity of illness scoring systems for intensive care unit patients: Results of a multicenter, multinational study. Crit Care Med 1995; 23:1327-1335
28. 28. Ghillani PP, Motté P, Troalen F, et al: Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res 1989; 49: 6845-6851
29. 29. Becker KL, Nylen ES, Cohen R, et al: Calcitonin: Structure, molecular biology, and actions. In: Principles of Bone Biology. Bilezikian JP, Raisz LG, Rodan GA (Eds). New York, Academic Press, 1996, pp 471-494
30. 30. Nylen ES, Jeng J, Jordan MH, et al: Late pulmonary sequela following burns: Persistence of hyperprocalcitonemia using a 1-57 amino acid N-terminal flanking peptide assay. Respir Med 1995; 89:41-46
31. 31. Whang KT, Steinwald PM, White JC, et al: Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998; 83:3296-3301
32. 32. Snider RH, Nylen ES, Becker KL: Procalcitonin and its component peptides in systemic inflammation: Immunochemical characterization. J Invest Med 1997; 45:552-560
33. 33. Zweig MH, Campbel G: Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39:561-577. [Erratum published in Clin Chem 1993; 39:1589]
34. 34. Griner PF, Mayewski RJ, Mushlin AI, et al: Selection and interpretation of diagnostic tests and procedures. Ann Intern Med 1981; 94:555-600
35. 35. Altman DG: Practical statistics for medical research. First Edition. London, Chapman & Hall, 1991
36. 36. Fassbender K, Pargger H, Müller W, et al: Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: Diagnostic signs in nosocomial infections. Crit Care Med 1993; 21: 1175-1180
37. 37. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273:117-123
38. 38. van Dissel JT, van Langevelde P, Westendorp RGJ, et al: Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351:950-953
39. 39. Vincent JL: Dear SIRS, I'm sorry to say that I don't like you. . . Crit Care Med 1997; 25: 372-374
40. 40. Van Snick J: Interleukin-6. An overview. Annu Rev Immunol 1990; 8:253-278
41. 41. Hoch RC, Rodriguez R, Manning T, et al: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21:839-845
42. 42. Casey L, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with septic syndrome. Ann Intern Med 1993; 119:771-778
43. 43. de Groote MA, Martin MA, Densen P, et al: Plasma tumor necrosis factor levels in patients with presumed sepsis. JAMA 1989; 262: 249-251
44. 44. Damas P, Canivet JL, De Groote D, et al: Sepsis and serum cytokine concentrations. Crit Care Med 1997; 25:405-412
45. 45. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:65-75
46. 46. Calandra T, Gerain J, Heumann D, et al: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91:23-29
47. 47. Meisner M, Tschaikowsky K, Schnabel S, et al: Procalcitonin - Influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem 1997; 35:597-601
48. 48. Canale DD, Donabedian RK: Hypercalcitonemia in acute pancreatitis. J Clin Endocrinol Metab 1975; 40:738-741
49. 49. Rau B, Steinbach G, Gansauge F, et al: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41:832-840
50. 50. Nylen ES, Snider RH Jr, Thompson KA, et al: Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 1996; 312:12-18
51. 51. O'Neill WJ, Jordan MH, Lewis MS, et al: Serum calcitonin may be a marker for inhalation injury in burns. J Burn Care Rehabil 1992; 13:605-616
52. 52. Nylen ES, O'Neill W, Jordan MH, et al: Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 1992; 24: 439-442
53. 53. Nylen ES, Arifi A, Becker KL, et al: Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997; 25:1362-1365
54. 54. Davis TME, Assicot M, Bohuon C, et al: Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 1994; 88:670-671
55. 55. Gérard Y, Hober D, Petitjean S, et al: High serum procalcitonin level in a 4-year-old liver transplant recipient with disseminated candidiasis. Infection 1995; 5:310-311
56. 56. Gendrel D, Raymond J, Assicot M, et al: Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24:1240-1242
57. 57. Swank GM, Deitch EA: Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg 1996; 20:411-417
58. 58. Nylen ES, Whang KT, White JC: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26: 1001-1006